Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:52 PM UTC
| NCT Number | NCT05592626 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 366 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Marengo Therapeutics, Inc. |
| Last Updated on CT.gov | August 11, 2026 (Aug 11, 2026) |
As of October 16, 2026: Clinical trial NCT05592626 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 13 locations across the United States. The study is sponsored by Marengo Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05592626 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05592626 was last updated Aug 11, 2026 (August 11, 2026). HelloStudys verifies this status automatically.